Literature DB >> 15049697

Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL.

Vladimir V Bamm1, Vladimir A Tsemakhovich, Matityahu Shaklai, Nurith Shaklai.   

Abstract

LDL oxidation plays a pivotal role in atherosclerosis. Excellular hemoglobin (Hb) is a trigger of LDL oxidation. By virtue of its ability to bind hemoglobin, haptoglobin (Hp) serves as an antioxidant. Oxidation of LDL by hemoglobin was analyzed to occur by heme displacement from methemoglobin lodged in LDL. The LDL-associated heme is disintegrated, and iron inserted this way in LDL triggers formation of lipid peroxides. The genetic polymorphism of haptoglobin was found to be a risk factor in the pathogenesis of atherosclerosis. Individuals with Hp2-2 have more vascular incidences as compared to those with Hp1-1. In the current study, oxidation of LDL by metHb was carried out at physiological pH without addition of external peroxides. Hb-derived oxidation of lipids and protein was found to be practically inhibited by Hp1-1 but only partially by Hp2-2. Heme transfer from metHb to LDL was almost completely omitted by Hp1-1 and only partially by Hp2-2. We concluded that partial heme transfer from the Hb-Hp2-2 complex to LDL is the reason for oxidation of LDL lipids as well as protein. These findings provide a molecular basis for Hp2-2 atherogenic properties.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15049697     DOI: 10.1021/bi0362626

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  39 in total

1.  Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.

Authors:  Tina Costacou; Andrew P Levy; Rachel G Miller; Janet Snell-Bergeon; Rabea Asleh; Dan Farbstein; Catherine E Fickley; Georgia Pambianco; Rona de la Vega; Rhobert W Evans; Trevor J Orchard
Journal:  Acta Diabetol       Date:  2015-05-24       Impact factor: 4.280

Review 2.  Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?

Authors:  Moshe Vardi; Andrew P Levy
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

3.  Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?

Authors:  Vladimir V Bamm; George Harauz
Journal:  Cell Mol Life Sci       Date:  2014-02-07       Impact factor: 9.261

4.  Haptoglobin genotype-dependent differences in macrophage lysosomal oxidative injury.

Authors:  Rabea Asleh; John Ward; Nina S Levy; Shady Safuri; Doron Aronson; Andrew P Levy
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

Review 5.  HDL dysfunction in diabetes: causes and possible treatments.

Authors:  Dan Farbstein; Andrew P Levy
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-03

Review 6.  Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.

Authors:  Moshe Vardi; Shany Blum; Andrew P Levy
Journal:  Eur J Intern Med       Date:  2012-05-14       Impact factor: 4.487

7.  The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaque.

Authors:  Shiri Kalet-Litman; Pedro R Moreno; Andrew P Levy
Journal:  Atherosclerosis       Date:  2009-09-06       Impact factor: 5.162

8.  Divergent effects of alpha-tocopherol and vitamin C on the generation of dysfunctional HDL associated with diabetes and the Hp 2-2 genotype.

Authors:  Rabea Asleh; Andrew P Levy
Journal:  Antioxid Redox Signal       Date:  2010-02       Impact factor: 8.401

Review 9.  Heme degradation and vascular injury.

Authors:  John D Belcher; Joan D Beckman; Gyorgy Balla; Jozsef Balla; Gregory Vercellotti
Journal:  Antioxid Redox Signal       Date:  2010-02       Impact factor: 8.401

10.  Sustained treatment of sickle cell mice with haptoglobin increases HO-1 and H-ferritin expression and decreases iron deposition in the kidney without improvement in kidney function.

Authors:  Patricia A Shi; Erika Choi; Narendranath R Chintagari; Julia Nguyen; Xinhua Guo; Karina Yazdanbakhsh; Narla Mohandas; Abdu I Alayash; Elizabeth A Manci; John D Belcher; Gregory M Vercellotti
Journal:  Br J Haematol       Date:  2016-08-10       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.